Krug B - Search Results

1

Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis.

Dornelles AD, Junges APP, Krug B, Gonçalves C, de Oliveira Junior HA, Schwartz IVD. Dornelles AD, et al. Among authors: krug b. Front Pediatr. 2024 Feb 15;12:1310317. doi: 10.3389/fped.2024.1310317. eCollection 2024. Front Pediatr. 2024. PMID: 38425665 Free PMC article. Review.

2

The management of Gaucher disease in developing countries: a successful experience in Southern Brazil.

Krug BC, Schwartz IV, Lopes de Oliveira F, Alegra T, Campos Martins NL, Todeschini LA, Picon PD. Krug BC, et al. Public Health Genomics. 2010;13(1):27-33. doi: 10.1159/000217793. Epub 2009 May 4. Public Health Genomics. 2010. PMID: 19407439

3

[Comments on the article <<Neonatal cholestasis revealing an intermediate phenotype of Gaucher disease, type 2>>].

Schwartz IV, Krug B, Picon PD. Schwartz IV, et al. Among authors: krug b. Arch Pediatr. 2009 Aug;16(8):1190-1. doi: 10.1016/j.arcped.2009.04.012. Epub 2009 Jun 10. Arch Pediatr. 2009. PMID: 19520555 French. No abstract available.

4

Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I.

Boy R, Schwartz IV, Krug BC, Santana-da-Silva LC, Steiner CE, Acosta AX, Ribeiro EM, Galera MF, Leivas PG, Braz M. Boy R, et al. J Med Ethics. 2011 Apr;37(4):233-9. doi: 10.1136/jme.2010.037150. Epub 2011 Jan 25. J Med Ethics. 2011. PMID: 21266385

5

Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis.

Alegra T, Vairo F, de Souza MV, Krug BC, Schwartz IV. Alegra T, et al. Genet Mol Biol. 2012 Dec;35(4 (suppl)):947-54. doi: 10.1590/s1415-47572012000600009. Epub 2012 Dec 18. Genet Mol Biol. 2012. PMID: 23413206 Free PMC article.

6

Quality of life of brazilian patients with Gaucher disease and fabry disease.

Oliveira FL, Alegra T, Dornelles A, Krug BC, Netto CB, da Rocha NS, Picon PD, Schwartz IV. Oliveira FL, et al. Among authors: krug bc. JIMD Rep. 2013;7:31-7. doi: 10.1007/8904_2012_136. Epub 2012 Apr 18. JIMD Rep. 2013. PMID: 23430492 Free PMC article.

7

A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease.

Dornelles AD, Junges APP, Pereira TV, Krug BC, Gonçalves CBT, Llerena JC Jr, Kishnani PS, de Oliveira HA Jr, Schwartz IVD. Dornelles AD, et al. J Clin Med. 2021 Oct 21;10(21):4828. doi: 10.3390/jcm10214828. J Clin Med. 2021. PMID: 34768348 Free PMC article. Review.

8

Efficacy and safety of onasemnogene abeparvovec for the treatment of patients with spinal muscular atrophy type 1: A systematic review with meta-analysis.

Fernandes BD, Krug BC, Rodrigues FD, Cirilo HNC, Borges SS, Schwartz IVD, Probst LF, Zimmermann I. Fernandes BD, et al. Among authors: krug bc. PLoS One. 2024 May 7;19(5):e0302860. doi: 10.1371/journal.pone.0302860. eCollection 2024. PLoS One. 2024. PMID: 38713659 Free PMC article.

9

[Court-ordered access to treatment of rare genetic diseases: Fabry Disease in the state of Rio Grande do Sul, Brazil].

Sartori Junior D, Leivas PG, Souza MV, Krug BC, Balbinotto G, Schwartz IV. Sartori Junior D, et al. Cien Saude Colet. 2012 Oct;17(10):2717-28. doi: 10.1590/s1413-81232012001000020. Cien Saude Colet. 2012. PMID: 23099758 Free article. Portuguese.

10

Disparity in the use of Alzheimer's disease treatment in Southern Brazil.

De Marco M, Brandi AL, Bieger A, Krug B, Camozzato A, Picon PD, Chaves MLF, Castilhos RM. De Marco M, et al. Among authors: krug b. Sci Rep. 2023 Jun 12;13(1):9555. doi: 10.1038/s41598-023-36604-4. Sci Rep. 2023. PMID: 37308535 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters